Mufid Othman, MD
Nephrology · Macon, GANPI 1962493379
Payments from drug & device makers
Across 23 payments — averaging $28.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$132
- Medtronic$103
- Mallinckrodt Hospital Products Inc.$99
- Travere Therapeutics, Inc.$91
- Smith+Nephew$88
- Boston Scientific$75
- plus $71 from 4 others
What the payments were for
- Food & beverage$58989%
- Education$7011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1 | $132 |
| Medtronic | 1 | $103 |
| Mallinckrodt Hospital Products Inc. | 3 | $99 |
| Travere Therapeutics, Inc. | 12 | $91 |
| Smith+Nephew | 1 | $88 |
| Boston Scientific | 1 | $75 |
| Novo Nordisk | 1 | $23 |
| Fresenius USA Marketing, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$659 in reported general payments places this provider in the 30th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $12,691 |
| Cinacalcet Hcl | 11 | $3,051 |
| ProsolParenteral Amino Acid 20% No.1 | 15 | $1,701 |
| Sevelamer Carbonate | 16 | $1,202 |
| Labetalol Hcl | 12 | $547 |
| Losartan Potassium | 50 | $451 |
| Atorvastatin Calcium | 47 | $345 |
| Allopurinol | 37 | $259 |
| Tamsulosin Hcl | 17 | $259 |
| Bumetanide | 12 | $237 |
| Quetiapine Fumarate | 19 | $203 |
| Rosuvastatin Calcium | 17 | $197 |
| Calcitriol | 15 | $188 |
| Furosemide | 47 | $168 |
| ClopidogrelClopidogrel Bisulfate | 21 | $164 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Macon
- Sagar PanseMacon$1.1M
- Niraj DesaiMacon$129K
- Carlos MartinezMacon$126K
- Kimathi BlackwoodMacon$64K
- Reuben EllisMacon$27K
- Ahmad KabbaniMacon$16K
- James TumlinLawrenceville$19.8M
- Chinedu NwekeAcworth$3.9M
- Vinayak RamanathLagrange$3.1M
- Harold HubertAugusta$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.